Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclophosphamide and whole organ transplantation in human beings.

× No keyword cloud information.

18 in total

1. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Authors: T E Starzl; T L Marchioro; K A Porter; Y Iwasaki; G J Cerilli
Journal: Surg Gynecol Obstet Date: 1967-02

2. Immunosuppressive therapy of ocular inflammatory diseases.

Authors: V G Wong
Journal: Arch Ophthalmol Date: 1969-05

3. "Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.

Authors: R K Laros; J A Penner
Journal: JAMA Date: 1971-01-18 Impact factor: 56.272

Review 4. Symposium on immunosuppressive drugs. Some biochemical effects of alkylating agents.

Authors: G P Wheeler
Journal: Fed Proc Date: 1967 May-Jun

Review 5. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

Authors: G B Elion
Journal: Fed Proc Date: 1967 May-Jun

6. Cyclophosphamide in renal homotransplantation.

Authors: F M Parsons; M Fox; C K Anderson; C Markland; P B Clark; F P Raper
Journal: Br J Urol Date: 1966-12

7. Cyclophosphamide therapy of peripheral uveitis.

Authors: C E Buckley; J P Gills
Journal: Arch Intern Med Date: 1969-07

8. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

Authors: R H White; J S Cameron; J R Trounce
Journal: Br Med J Date: 1966-10-08

9. Cyclophosphamide in the treatment of systemic lupus erythematosus.

Authors: C Siang; K H Wong; A G Chew; F J Jayaratnam
Journal: Br Med J Date: 1966-02-05

10. Cyclophosphamide therapy in the nephrotic syndrome in childhood.

Authors: M W Moncrieff; R H White; C S Oggs; J S Cameron
Journal: Br Med J Date: 1969-03-15

28 in total

1. History of clinical transplantation.

Authors: T E Starzl
Journal: World J Surg Date: 2000-07 Impact factor: 3.352

2. Factors in the Development of Liver Transplantation.

Authors: T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel; S Todo; I Kam; S Lynch
Journal: Transplant Proc Date: 1985-10 Impact factor: 1.066

3. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.

Authors: A Langer; L A Valdivia; N Murase; J Woo; S Celli; J J Fung; T E Starzl; A J Demetris
Journal: Am J Pathol Date: 1993-07 Impact factor: 4.307

Cyclophosphamide and whole organ transplantation in human beings.

1. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

2. Immunosuppressive therapy of ocular inflammatory diseases.

3. "Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.

Review 4. Symposium on immunosuppressive drugs. Some biochemical effects of alkylating agents.

Review 5. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

6. Cyclophosphamide in renal homotransplantation.

7. Cyclophosphamide therapy of peripheral uveitis.

8. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

9. Cyclophosphamide in the treatment of systemic lupus erythematosus.

10. Cyclophosphamide therapy in the nephrotic syndrome in childhood.

1. History of clinical transplantation.

2. Factors in the Development of Liver Transplantation.

3. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.

4.

5. Liver transplantation in the ciclosporin era.

6. The Future of Xenotransplantation.

7. Personal reflections in transplantation.

8. Kidney transplantation. Modern trends in kidney transplantation.

9. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.

10. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.